Appleton Partners’s Idexx Laboratories IDXX Stock Holding History

Appleton Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-415	Closed	-$207K	–	282
2020 Q4	$207K	Buy	+415	New	+$186K	0.02%	267

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Appleton Partners's IDXX Position: Q1 2021 in Review

Appleton Partners sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 415 shares — an estimated $207K sold.

Appleton Partners first reported a position in IDXX in Q4 2020 and held it in 1 quarter. The position peaked at $207K in Q4 2020. 1,011 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

Appleton Partners reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
Appleton Partners sold 415 Idexx Laboratories shares in Q1 2021, an estimated $207K.
Appleton Partners first reported a position in Idexx Laboratories in Q4 2020 and held it in 1 quarter.
Appleton Partners's Idexx Laboratories position peaked at $207K in Q4 2020.
1,011 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Appleton Partners's 13F filing for Q1 2021, filed 19 Apr 2021.